Innovation
MB Research Laboratories, a GLP contract research laboratory, has been conducting acute, subchronic / chronic toxicology and pharmacology studies since 1972. With expertise in many areas of in vivo and in vitro testing, research, and safety evaluations, MB Research serves the testing needs of both government and industry. Complete support services including consultation, protocol development, quality assurance, analytical chemistry and archive facilities are integral components of studies performed at MB. Our technical and support procedures are in full compliance with OECD, FDA, and EPA. For more information about our capabilities, please click here.
For over 10 years we have been validating and conducting alternative tests beginning with the Chorioallantoic Membrane Vascular Assay, (CAMVA) followed by the Bovine Corneal Opacity and Permeability Test (BCOP). MB expanded its in vitro capabilities by offering the Corrositex assay in 1996 as an alternative to dermal corrosivity tests. In 1997, MB's cell culture and in vitro laboratories began to regularly conduct a variety of assays including cytotoxicity tests, enzyme assays, cytokine and inflammation mediator assays in monolayer cultures and tissue equivalent systems such as MatTek EpiOcular™, EpiDerm™, and MelanoDerm™.
Where are we located?
MB Research is conveniently located along the Northeast extension of the Pennsylvania Turnpike between Allentown and Philadelphia about 1 1/2 hr west of New York City. We would be happy to arrange a site visit at your convenience. Want to know more about MB Research? Read about our facilities
Download our informational packet about MB Research Labs.
